Health Catalyst, a Utah-based healthcare analytics company, raised its valuation to over $1 billion after its Series F equity and debt funding round led by OrbiMed Advisors.
Steven Loeb tells us more about Health Catalyst in this report from VatorNews:
Around $15 million of the round was in the form of equity, giving Health Catalyst a total of roughly $315 million in venture funding and a $1 billion valuation, positioning it as the latest “unicorn.” This achievement, Dan Burton, CEO of Health Catalyst, told me in an interview, is just a “mile marker,” though one that “insinuates that some of the things that we focused on are bearing fruit and are helping the company progress and realize success.”
“In no way are we where we need to be from the perspective of accomplishing our mission. Our mission is to unleash data to enable massive improvement and real transformation in the healthcare ecosystem. We have a long way to go in achieving that mission and a lot of work to do,” he said. “This helps us celebrate for a moment the work of the last 10 and a half years, and then quickly turn forward to work before us over the next 10 or 20 or 30 years and keep progressing on our journey.”
Founded in 2008, the Salt Lake City-based Health Catalyst creates software for hospitals manage their data processes. The platform pulls in data from a wide variety of sources, and then provides analytics and outcomes to help healthcare organizations improve the clinical, financial, and operational reporting and analysis needed for population health and accountable care.
In the last year or so, the company has launched some clinical, financial and operational analytics application suites to help its clients take more action with the data Health Catalyst provides.
